- Todo
- Eventos y Exposiciones
- Noticias corporativas
noviembre 10, 2020
Dompe’ farmaceutici and the FarmaMondo Group: exclusive agreement to distribute oxervate™ in Russia and other CIS countries
abril 14, 2020
EUSA and FarmaMondo Group establishes an Emergency Managed Access Program to allow Healthcare Providers to access Siltuximab (Sylvant©) for off label treatment of acute patients of COVID-19
junio 1, 2020
FarmaMondo to exclusively manage access to Metreleptin (Myalept®) by Amryt Pharma for patients with lipodystrophy in CIS (excluding Russia)
octubre 2, 2019
FarmaMondo to exclusively Manage Access to Lomitapide (Lojuxta®) for the Swiss and CIS markets
junio 1, 2019
FarmaMondo to exclusively manage access of Qarziba® (Dinutuximab Beta) by EUSA Pharma for patients with High Risk Neuroblastoma in LATAM and APAC regions
agosto 20, 2018
FarmaMondo to manage access to Asparaginase (Spectrila® by Medac Pharma) for patients with acute lymphoblastic leukemia in Russia and CIS region
marzo 15, 2018
FarmaMondo appointed by Amomed Pharma to exclusively Manage Access for Argipressin (Empressin®) for Russia and CIS region
enero 1, 2018
FarmaMondo establishes presence in south EU markets to provide direct to hospital service around supply of unlicensed medicines
noviembre 1, 2017
FarmaMondo establishes presence in Mexico to provide direct to hospital service around supply of unlicensed medicines
octubre 17, 2017
FarmaMondo to manage access to Dinutuximab beta EUSA for patients with Neuroblastoma
octubre 17, 2017
FarmaMondo to manage access to Qarziba® (Dinutuximab Beta) by EUSA Pharma) for patients with High Risk Neuroblastoma in Russia and CIS region
agosto 15, 2013